Market Research Logo

Biosimilars Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017–2025

Biosimilars Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017–2025

Biosimilars are biopharmaceutical drugs that have active components and are similar to the drugs, which have been previously licensed. They are identical copies of the original product and can be manufactured only when the patent for the original innovator product expires. Biosimilars are majorly used in therapeutic applications for the treatment of various types of cancer and non-communicable diseases (asthma and arthritis).

Increasing prevalence of cancer is expected to boost growth of the biosimilars market. For instance, according to National Institute of Cancer Prevention and Research (NICPR), in 2018, 1,62,468 new cases and 87,090 deaths were reported due to breast cancer in India. Biosimilars are designed to be highly similar to originator biologic products, which represents an opportunity to increase access and reduce costs for patients and healthcare systems.

Market Dynamics

Increasing number of biosimilar approvals in clinical management of various diseases such as diabetes and hormonal imbalance is expected to drive growth of the biosimilars market. According to the Generics and Biosimilars Initiative (GABI) 2017 report, around 40 different biosimilars were approved in Europe, covering several different therapeutic classes: granulocyte colony-stimulating factors, and erythropoiesis-stimulating agents (ESAs), among others.

Moreover, increasing research and development in biosimilars, robust biosimilar pipeline portfolio, and support from healthcare regulatory bodies in fast lining biosimilar approvals are some of the major factors that are expected to drive growth of the market. The U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) both provide guidance for the development of biosimilar drugs. However, stringent regulatory guidelines for development and manufacturing of biosimilars and fragile process of biosimilars production are expected to negatively impact growth of the global biosimilars market.

Key features of the study:

  • This report provides in-depth analysis of the biosimilars market, market size (US$ Mn), and Compound Annual Growth Rate (CAGR (%)) for the forecast period: 2018 – 2026, considering 2017, as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global biosimilars market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
  • Key players covered as a part of this study include Novartis AG, Pfizer, Inc., Teva Pharmaceutical Industries Ltd., Celltrion Healthcare Co., Ltd., Biocon Limited, Amgen, Inc., Dr. Reddy's Laboratories, and Sanofi S.A.
  • Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, government initiatives, technological up-gradation, market expansion, and marketing tactics
  • The global biosimilars market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for biosimilars market, research and consulting firms, new entrants, and financial analysts
Detailed Segmentation:
  • Global Biosimilars Market, By Drug Class:
  • Recombinant Human Growth Hormone
  • Granulocyte Colony-Stimulating Factor
  • Insulin
  • Anticoagulants
  • Fusion Proteins
  • Erythropoietin
  • Monoclonal Antibodies
  • Follitropin
  • Others
  • Global Biosimilars Market, By Therapy Type:
  • Oncology
  • Immunology
  • Hematology
  • Hormone Therapy
  • Metabolic Disorders
  • Others
  • Global Biosimilars Market, By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Specialty Pharmacies
  • Global Biosimilars Market, By Region:
  • North America
  • By Country:
  • U.S.
  • Canada
  • By Drug Class:
  • Recombinant Human Growth Hormone
  • Granulocyte Colony-Stimulating Factor
  • Insulin
  • Anticoagulants
  • Fusion Proteins
  • Erythropoietin
  • Monoclonal Antibodies
  • Follitropin
  • Others
  • By Therapy Type:
  • Oncology
  • Immunology
  • Hematology
  • Hormone Therapy
  • Metabolic Disorders
  • Others
  • By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Specialty Pharmacies
  • Europe
  • By Country:
  • U.K.
  • Germany
  • Italy
  • Spain
  • France
  • Russia
  • Rest of Europe
  • By Drug Class:
  • Recombinant Human Growth Hormone
  • Granulocyte Colony-Stimulating Factor
  • Insulin
  • Anticoagulants
  • Fusion Proteins
  • Erythropoietin
  • Monoclonal Antibodies
  • Follitropin
  • Others
  • By Therapy Type:
  • Oncology
  • Immunology
  • Hematology
  • Hormone Therapy
  • Metabolic Disorders
  • Others
  • By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Specialty Pharmacies
  • Asia Pacific
  • By Country:
  • Australia
  • India
  • China
  • Japan
  • ASEAN
  • South Korea
  • Rest of Asia Pacific
  • By Drug Class:
  • Recombinant Human Growth Hormone
  • Granulocyte Colony-Stimulating Factor
  • Insulin
  • Anticoagulants
  • Fusion Proteins
  • Erythropoietin
  • Monoclonal Antibodies
  • Follitropin
  • Others
  • By Therapy Type:
  • Oncology
  • Immunology
  • Hematology
  • Hormone Therapy
  • Metabolic Disorders
  • Others
  • By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Specialty Pharmacies
  • Latin America
  • By Country:
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • By Drug Class:
  • Recombinant Human Growth Hormone
  • Granulocyte Colony-Stimulating Factor
  • Insulin
  • Anticoagulants
  • Fusion Proteins
  • Erythropoietin
  • Monoclonal Antibodies
  • Follitropin
  • Others
  • By Therapy Type:
  • Oncology
  • Immunology
  • Hematology
  • Hormone Therapy
  • Metabolic Disorders
  • Others
  • By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Specialty Pharmacies
  • Middle East
  • By Country:
  • GCC
  • Israel
  • Rest of Middle East
  • By Drug Class:
  • Recombinant Human Growth Hormone
  • Granulocyte Colony-Stimulating Factor
  • Insulin
  • Anticoagulants
  • Fusion Proteins
  • Erythropoietin
  • Monoclonal Antibodies
  • Follitropin
  • Others
  • By Therapy Type:
  • Oncology
  • Immunology
  • Hematology
  • Hormone Therapy
  • Metabolic Disorders
  • Others
  • By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Specialty Pharmacies
  • Africa
  • By Country:
  • South Africa
  • Central Africa
  • North Africa
  • By Drug Class:
  • Recombinant Human Growth Hormone
  • Granulocyte Colony-Stimulating Factor
  • Insulin
  • Anticoagulants
  • Fusion Proteins
  • Erythropoietin
  • Monoclonal Antibodies
  • Follitropin
  • Others
  • By Therapy Type:
  • Oncology
  • Immunology
  • Hematology
  • Hormone Therapy
  • Metabolic Disorders
  • Others
  • By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Specialty Pharmacies
  • Company Profiles
  • Novartis AG *
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
  • Pfizer, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Celltrion Healthcare Co., Ltd.
  • Biocon Limited
  • Amgen, Inc.
  • Dr. Reddy's Laboratories
  • Sanofi S.A.
“*” marked represents similar segmentation in other categories in the respective section.


1. Research Objective and Assumption
Research Objectives
Assumptions
Abbreviations
2. Market Overview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Drug Class
Market Snippet, By Therapy Type
Market Snippet, By Distribution Channel
Market Snippet, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Market Trends
Key Developments
Pipeline Analysis
Supply Chain Analysis
Cost Effectiveness of Biosimilars
Reimbursement Scenario
Regulatory Landscape
Epidemiology Analysis
PEST Analysis
Porter’s Five Forces model
4. Global Biosimilars Market, By Drug Class, 2018 – 2026, (US$ Million)
Introduction
Market Share Analysis, 2018 and 2026 (%)
Y-o-Y Growth Analysis, 2017 – 2026
Segment Trends
Recombinant Human Growth Hormone (rhGH)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
Granulocyte Colony-Stimulating Factor (Filgrastim)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
Insulin
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
Anticoagulants
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
Fusion Proteins
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
Erythropoietin (EPO)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
Monoclonal Antibodies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
Follitropin
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
5. Global Biosimilars Market, By Therapy Type, 2018 – 2026, (US$ Million)
Introduction
Market Share Analysis, 2018 and 2026 (%)
Y-o-Y Growth Analysis, 2017 – 2026
Segment Trends
Oncology
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
Immunology
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
Hematology
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
Hormone Therapy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
Metabolic Disorders
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
6. Global Biosimilars Market, By Distribution Channel, 2018 – 2026, (US$ Million)
Introduction
Market Share Analysis, 2018 and 2026 (%)
Y-o-Y Growth Analysis, 2017 – 2026
Segment Trends
Hospital Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
Specialty Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
7. Global Biosimilars Market, By Region, 2018 – 2026, (US$ Million)
Introduction
Market Share Analysis, By Region, 2018 and 2026 (%)
Y-o-Y Growth Analysis, By Region, 2017 – 2026
Regional Trends
North America
Market Size and Forecast, By Drug Class, 2018 – 2026, (US$ Million)
Market Size and Forecast, By Therapy Type, 2018 – 2026, (US$ Million)
Market Size and Forecast, By Distribution Channel, 2018 – 2026, (US$ Million)
Market Size and Forecast, By Country, 2018 – 2026, (US$ Million)
U.S.
Canada
Europe
Market Size and Forecast, By Drug Class, 2018 – 2026, (US$ Million)
Market Size and Forecast, By Therapy Type, 2018 – 2026, (US$ Million)
Market Size and Forecast, By Distribution Channel, 2018 – 2026, (US$ Million)
Market Size and Forecast, By Country, 2018 – 2026, (US$ Million)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Market Size and Forecast, By Drug Class, 2018 – 2026, (US$ Million)
Market Size and Forecast, By Therapy Type, 2018 – 2026, (US$ Million)
Market Size and Forecast, By Distribution Channel, 2018 – 2026, (US$ Million)
Market Size and Forecast, By Country, 2018 – 2026, (US$ Million)
China
Japan
India
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
Market Size and Forecast, By Drug Class, 2018 – 2026, (US$ Million)
Market Size and Forecast, By Therapy Type, 2018 – 2026, (US$ Million)
Market Size and Forecast, By Distribution Channel, 2018 – 2026, (US$ Million)
Market Size and Forecast, By Country, 2018 – 2026, (US$ Million)
Brazil
Mexico
Argentina
Rest of Latin America
Africa
Market Size and Forecast, By Drug Class, 2018 – 2026, (US$ Million)
Market Size and Forecast, By Therapy Type, 2018 – 2026, (US$ Million)
Market Size and Forecast, By Distribution Channel, 2018 – 2026, (US$ Million)
Market Size and Forecast, By Country, 2018 – 2026, (US$ Million)
North Africa
Central Africa
South Africa
Middle East
Market Size and Forecast, By Drug Class, 2018 – 2026, (US$ Million)
Market Size and Forecast, By Therapy Type, 2018 – 2026, (US$ Million)
Market Size and Forecast, By Distribution Channel, 2018 – 2026, (US$ Million)
Market Size and Forecast, By Country, 2018 – 2026, (US$ Million)
GCC Countries
Israel
Rest of Middle East
8. Competitive Landscape
Company Profiles
Novartis AG
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Pfizer, Inc.
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Teva Pharmaceutical Industries Ltd.
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Celltrion Healthcare Co., Ltd.
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Biocon Limited
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Amgen, Inc.
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Dr. Reddy's Laboratories
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Sanofi S.A.
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Analyst Views
9. Section
References
Research Methodology
About Us and Sales Contact
*Browse 27 market data tables and 21 figures on "Biosimilars Market” - Global forecast to 2026”

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report